NGR004:A Phase IB Study of NGR-hTNF in Combination With Cisplatin in Patient Affected by Advanced or Metastatic Solid Tumor
Phase of Trial: Phase I
Latest Information Update: 11 Jul 2014
At a glance
- Drugs NGR-TNF (Primary) ; Cisplatin
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors MolMed
- 03 Jan 2012 Additional lead trial investigator (Antonio Lambaise) identified as reported by ClinicalTrials.gov.
- 14 Feb 2011 Results published in Clinical Cancer Research.
- 24 Sep 2009 Long-term follow-up results have been presented at the joint Annual Meeting of the European Cancer Organisation and of the European Society of Medical Oncology (ECCO-ESMO), according to a MolMed media release.